Comparative analysis of anxiety and depression indicators in inpatient patients of the occupational diseases clinic in the treatment of patients with COVID-19-Reference-Cited by-同舟云学术

Comparative analysis of anxiety and depression indicators in inpatient patients of the occupational diseases clinic in the treatment of patients with COVID-19

Published:2021-07-12 Issue:5 Volume:61 Page:330-333
ISSN:2618-8945
Container-title:Russian Journal of Occupational Health and Industrial Ecology
language:
Short-container-title:Med. tr. prom. èkol.

Author:

Zhovnerchuk Evgeny V.¹,Musailov Vitaly A.²,Khatin Dmitry E.³,Rumyantceva Olga I.³,Serikov Vasiliy V.³,Moskovenko Alexey N.³

Affiliation:

1. Izmerov Research Institute of Occupational Health; Academy of Postgraduate Education of the Federal Research and Clinical Center of the Federal Medical and Biological Agency of Russia; Academy of Administration of the Ministry of Internal Affairs of Russia

2. Branch No. 1 of the 3rd Central Military Clinical Hospital named after A.A. Vishnevsky; Military Medical Academy named after C.M. Kirov

3. Izmerov Research Institute of Occupational Health

Abstract

Anxiety and depression can be comorbid diseases, or they can also be psychogenic complications for information about your condition. Therefore, it is essential to know how the patient's personality reacts to the awareness of his illness. The study aims to conduct a comparative analysis of indicators of anxiety and depression in patients of the occupational health clinic with various diseases, including COVID-19. Based on the screening results, we studied the need to change the tactics of organizing psychological and psychiatric care for the treatment of anxiety and depression in the Occupational Diseases Clinic after its conversion to treat patients with COVID-19.

Publisher

FSBI Research Institute of Occupational Health RAMS

Subject

General Medicine

Reference16 articles.

1. Alves de Lima K., Rustenhoven J., Da Mesquita S. et al. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nature Immunology (2020). https://doi.org/10.1038/s41590-020-0776-4

2. Mordvinov V.A., Furman D.P. Cytokines: biological properties and regulation of human interleukin-5 gene expression. Vestnik VOGiS. 2009; 13 (1): 53–67 (in Russian).

3. Ahmed Nadeema, Sheikh F. Ahmada, Naif O. Al-Harbia. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression. Cytokine. 2017; 97: 14–24. https://doi.org/10.1016/j.cyto.2017.05.018

4. Gloria B. Choi, Yeong S. Yim, Helen Wong et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016; 351(6276): 933–9. https://doi.org/10.1126/science.aad0314

5. Kessler R.C., Merikangas K.R., Wang P.S. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 2007; 3: 137–58. https://doi.org/10.1146/annurev.clinpsy.3.022806.091444